Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

CoViPoint COVID test kit (MultiPLEX/Direct) Kit Item Numbers: BC-DK0200 Recalled by GS Biomark LLC Due to Distribution of COVID Test Kits without FDA Approval,...

Date: August 8, 2022
Company: GS Biomark LLC
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact GS Biomark LLC directly.

Affected Products

CoViPoint COVID test kit (MultiPLEX/Direct) Kit Item Numbers: BC-DK0200; BM-AD4K0200 BM-ADK0200 BM-CDK0200 BM-CFDK0200 BM-D4K0200 BM-DK0200 BM-DK0600 BM-DK0800 BM-DK1200 BM-DK1400 BM-DK1800

Quantity: 639,200 kits

Why Was This Recalled?

Distribution of COVID Test Kits without FDA Approval, Clearance or Authorization.

Where Was This Sold?

This product was distributed to 11 states: CA, GA, IN, MD, NJ, NY, OR, PA, TX, WA, DC

Affected (11 states)Not affected

About GS Biomark LLC

GS Biomark LLC has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report